These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 24577894)
1. APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. Qi G; Xiong H; Zhou C Tumour Biol; 2014 Jun; 35(6):5723-6. PubMed ID: 24577894 [TBL] [Abstract][Full Text] [Related]
2. APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry. Xuan D; Li G; Cai Q; Deming-Halverson S; Shrubsole MJ; Shu XO; Kelley MC; Zheng W; Long J Carcinogenesis; 2013 Oct; 34(10):2240-3. PubMed ID: 23715497 [TBL] [Abstract][Full Text] [Related]
3. A common deletion in the APOBEC3 genes and breast cancer risk. Long J; Delahanty RJ; Li G; Gao YT; Lu W; Cai Q; Xiang YB; Li C; Ji BT; Zheng Y; Ali S; Shu XO; Zheng W J Natl Cancer Inst; 2013 Apr; 105(8):573-9. PubMed ID: 23411593 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of receptor for advanced glycation end products and risk of epithelial ovarian cancer in Chinese patients. Zhang S; Hou X; Zi S; Wang Y; Chen L; Kong B Cell Physiol Biochem; 2013; 31(4-5):525-31. PubMed ID: 23571222 [TBL] [Abstract][Full Text] [Related]
5. Roles of functional NFKB1 and β-TrCP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility. Huo ZH; Zhong HJ; Zhu YS; Xing B; Tang H Genet Mol Res; 2013 Mar; 12(3):3435-43. PubMed ID: 23546975 [TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women. Chen K; Ma H; Li L; Zang R; Wang C; Song F; Shi T; Yu D; Yang M; Xue W; Dai J; Li S; Zheng H; Wu C; Zhang Y; Wu X; Li D; Xue F; Li H; Jiang Z; Liu J; Liu Y; Li P; Tan W; Han J; Jie J; Hao Q; Hu Z; Lin D; Ma D; Jia W; Shen H; Wei Q Nat Commun; 2014 Aug; 5():4682. PubMed ID: 25134534 [TBL] [Abstract][Full Text] [Related]
7. Genetic variants of lncRNA HOTAIR and risk of epithelial ovarian cancer among Chinese women. Wu H; Shang X; Shi Y; Yang Z; Zhao J; Yang M; Li Y; Xu S Oncotarget; 2016 Jul; 7(27):41047-41052. PubMed ID: 27166268 [TBL] [Abstract][Full Text] [Related]
8. Relationship of WNT4 Gene with the Risk of Epithelial Ovarian Cancer: A Han Chinese Population-Based Association Study. Zhang J; Zhang P; Shen Y; Yang M; Zou H; Liu H Genet Test Mol Biomarkers; 2018 Dec; 22(12):686-692. PubMed ID: 30457351 [TBL] [Abstract][Full Text] [Related]
9. Association of androgen receptor CAG repeat polymorphism and risk of epithelial ovarian cancer. Zhu T; Yuan J; Xie Y; Li H; Wang Y Gene; 2016 Jan; 575(2 Pt 3):743-6. PubMed ID: 26410037 [TBL] [Abstract][Full Text] [Related]
10. WWOX CNV-67048 Functions as a Risk Factor for Epithelial Ovarian Cancer in Chinese Women by Negatively Interacting with Oral Contraceptive Use. Chen Y; Tan X; Ding Y; Mai B; Huang X; Hu G; Luo X Biomed Res Int; 2016; 2016():6594039. PubMed ID: 27190995 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women. Shi TY; Jiang Z; Jiang R; Yin S; Wang MY; Yu KD; Shao ZM; Sun MH; Zang R; Wei Q Tumour Biol; 2015 Sep; 36(9):6919-27. PubMed ID: 25854172 [TBL] [Abstract][Full Text] [Related]
12. BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer. Shi T; Wang P; Xie C; Yin S; Shi D; Wei C; Tang W; Jiang R; Cheng X; Wei Q; Wang Q; Zang R Int J Cancer; 2017 May; 140(9):2051-2059. PubMed ID: 28176296 [TBL] [Abstract][Full Text] [Related]
13. The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes. Li Y; Zhang HL; Kang S; Zhou RM; Wang N Gynecol Oncol; 2017 Jan; 144(1):140-145. PubMed ID: 27836206 [TBL] [Abstract][Full Text] [Related]
14. Association of a common variant of SYNPO2 gene with increased risk of serous epithelial ovarian cancer. Ma L; Zhang W; Ding Z; Wu SG; Jin Y; Jiang N; Du H; Cai D; Miao L; Chen X Tumour Biol; 2017 Feb; 39(2):1010428317691185. PubMed ID: 28231729 [TBL] [Abstract][Full Text] [Related]
16. Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients. Dholariya S; Mir R; Zuberi M; Yadav P; Gandhi G; Khurana N; Saxena A; Ray PC Clin Transl Oncol; 2016 Jan; 18(1):73-81. PubMed ID: 26209050 [TBL] [Abstract][Full Text] [Related]
17. APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. Han Y; Qi Q; He Q; Sun M; Wang S; Zhou G; Sun Y Oncotarget; 2016 Nov; 7(46):74979-74986. PubMed ID: 27602762 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of an APOBEC3 deletion polymorphism for glioma patients in Taiwan. Chen CH; Wei KC; Liao WC; Lin YY; Chen HC; Feng LY; Liu CH; Huang CY; Chen KT; Wu CS; Chang YS; Yu JS; Chang IY J Neurosurg; 2023 May; 138(5):1325-1337. PubMed ID: 36152319 [TBL] [Abstract][Full Text] [Related]
19. The AIB1 gene polyglutamine repeat length polymorphism contributes to risk of epithelial ovarian cancer risk: a case-control study. Han G; Xie S; Fang H; Li G; Han Y; Qin Z Tumour Biol; 2015 Jan; 36(1):371-4. PubMed ID: 25263716 [TBL] [Abstract][Full Text] [Related]
20. A polymorphism at miRNA-122-binding site in the IL-1α 3'UTR is associated with risk of epithelial ovarian cancer. Zhang Z; Zhou B; Gao Q; Wu Y; Zhang K; Pu Y; Song Y; Zhang L; Xi M Fam Cancer; 2014 Dec; 13(4):595-601. PubMed ID: 25195148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]